A phase III study for prevention of delayed nausea: A University of Rochester CCOP study of 1,021 patients receiving chemotherapy

Autor:	J. P. Kuebler, James L. Wade, Luke J. Peppone, Shaker R. Dakhil, Joseph A. Roscoe, Michelle C. Janelsins, Supriya G. Mohile, C. E. Heckler, Gary R. Morrow
Rok vydání:	2011
Předmět:	Cancer Research Chemotherapy business.industry Nausea medicine.drug_class medicine.medical_treatment First generation Oncology Anesthesia Medicine Antiemetic medicine.symptom business Dexamethasone medicine.drug
Zdroj:	Journal of Clinical Oncology. 29:9012-9012
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2011.29.15_suppl.9012
Popis:	9012 Background: Despite the widespread use of first generation serotonin receptor antagonists, dexamethasone (DEX) and a variety of other antiemetic medications, delayed nausea has continued to oc...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d0fc9fb1978167829c02583e573ece50 https://doi.org/10.1200/jco.2011.29.15_suppl.9012 Zobrazit plný text záznamu